"Uterine Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the UTERUS.
| Descriptor ID |
D014594
|
| MeSH Number(s) |
C04.588.945.418.948 C13.351.500.852.762 C13.351.937.418.875
|
| Concept/Terms |
Uterine Neoplasms- Uterine Neoplasms
- Neoplasms, Uterus
- Neoplasm, Uterus
- Uterus Neoplasm
- Uterus Neoplasms
- Neoplasms, Uterine
- Neoplasm, Uterine
- Uterine Neoplasm
Cancer of Uterus- Cancer of Uterus
- Uterus Cancers
- Cancer of the Uterus
- Uterus Cancer
- Cancer, Uterus
- Cancers, Uterus
- Uterine Cancer
- Cancer, Uterine
- Cancers, Uterine
- Uterine Cancers
|
Below are MeSH descriptors whose meaning is more general than "Uterine Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Uterine Neoplasms".
This graph shows the total number of publications written about "Uterine Neoplasms" by people in this website by year, and whether "Uterine Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 1 | 2 |
| 2000 | 1 | 1 | 2 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 0 | 2 |
| 2003 | 2 | 1 | 3 |
| 2004 | 2 | 0 | 2 |
| 2005 | 4 | 0 | 4 |
| 2006 | 7 | 0 | 7 |
| 2007 | 3 | 0 | 3 |
| 2008 | 3 | 0 | 3 |
| 2009 | 3 | 0 | 3 |
| 2010 | 4 | 2 | 6 |
| 2011 | 4 | 1 | 5 |
| 2012 | 4 | 1 | 5 |
| 2013 | 6 | 1 | 7 |
| 2014 | 6 | 0 | 6 |
| 2015 | 11 | 0 | 11 |
| 2016 | 9 | 4 | 13 |
| 2017 | 11 | 2 | 13 |
| 2018 | 16 | 1 | 17 |
| 2019 | 6 | 0 | 6 |
| 2020 | 15 | 0 | 15 |
| 2021 | 15 | 0 | 15 |
| 2022 | 20 | 0 | 20 |
| 2023 | 23 | 0 | 23 |
| 2024 | 18 | 1 | 19 |
| 2025 | 11 | 2 | 13 |
| 2026 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Uterine Neoplasms" by people in Profiles.
-
Exploring decision-making preferences around treatment in patients with advanced and recurrent uterine cancer. Int J Gynecol Cancer. 2026 Sep; 36(9):104834.
-
Vitamin D and Uterine Fibroids: Insights into Pathophysiology and Therapeutic Potential. Endocr Rev. 2026 May 13; 47(3):329-350.
-
Three-Dimensional Organoids Culturing and Processing Techniques for Myometrial and Uterine Fibroids Generation. J Vis Exp. 2026 04 30; (230).
-
Multi-omics Approaches for Biomarker Discovery of Uterine Fibroids: A Systematic Review. Adv Ther. 2026 Jun; 43(6):2474-2495.
-
Decoding Bromodomain and Extra-Terminal Domain Protein-Mediated Epigenetic Mechanisms in Human Uterine Fibroids. Int J Mol Sci. 2025 Dec 17; 26(24).
-
Mechanical Stiffness Influences the Response of Human Uterine Fibroid Cells to Hormonal Treatments. Reprod Sci. 2026 01; 33(1):129-140.
-
Transvaginal shear wave elastography for measuring uterine myometrial and leiomyoma stiffness: a protocol pilot study. F S Sci. 2026 01; 7(1):91-99.
-
Uterine fibroids - why you should choose tailored therapies based on the joint decision of the physician and the patient. Ginekol Pol. 2025; 96(7):519-523.
-
Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer. N Engl J Med. 2025 Jun 19; 392(23):2346-2356.
-
Dual Targeting EZH2 and Histone Deacetylases in Human Uterine Sarcoma Cells Under Both 2D and 3D Culture Conditions. J Cell Mol Med. 2025 06; 29(11):e70626.